Prostate Screening at IHS

Prostate Cancer in America

Did you know?

After skin cancer, prostate cancer is the most common cancer in men in the United States. It is the third leading cause of cancer death in American men, behind lung cancer and colorectal cancer. Prostate cancer is most prevalent in men over age 65 and fairly common in men 50-64 years old. However, prostate cancer can occur in men younger than 50. 1 in 7 men will develop prostate cancer during their lifetime, and about 1 in 39 men will die of prostate cancer.

Are you at risk?

Traditionally, men are screened for prostate cancer with a blood serum test called Prostate-Specific Antigen (PSA), and a Digital Rectal Exam (DRE). If either screening shows an abnormality, you may be at risk for prostate cancer.

If you have two or more of the following risk factors, you may benefit from screening with multiparametric prostate MRI (mpMRI):

  • Elevated prostate-specific antigen (PSA)
  • Family history of prostate cancer
  • African American
  • Over age 65
  • Overweight
  • Enlarged prostate
  • Abnormal digital examination
Call 858-888-4398 today to find out if mpMRI is right for you.


IHS provides important services for men to screen for prostate cancer, including prostate MRI and MRI-guided biopsy. For men diagnosed with prostate cancer, our advanced imaging technology may be used for “active surveillance”, as well as for treatment planning.